00:01
Let's start with a
case to understand why
this information is important.
00:05
This is a 53-year-old man
with liver disease
and recent hospitalization
for osteomyelitis,
who was placed on metronidazole
and moxifloxacin for six weeks.
00:17
The patient was recovering well
until about two weeks ago,
when he began to develop
gait ataxia and dysarthria.
00:23
So some cerebellar signs.
00:26
This is slowly worsened to the point
that he is having trouble walking.
00:29
Exam shows truncal ataxia,
difficulty with
keeping himself upright
dysarthric speech,
saccadic overshoot on
eye movement examination,
so he's having trouble
coordinating his eye movements.
00:41
Otherwise,
neurologic exam is unremarkable.
00:44
MRI is performed and reveals
T2-weighted hyperintense lesions
in the bilateral deep
cerebellar gray matter.
00:52
So what's the most likely diagnosis?
Well, as with other cases
of the brain and cerebellum,
the timeline of onset is important.
01:00
This is a subacute onset condition.
01:03
It's not acute like a stroke,
or an intoxication or trauma,
not chronic, like a
degenerative cerebellar disease.
01:09
This sounds like
something more in the
inflammatory, toxic,
or metabolic category.
01:16
The patient's description is that
of cerebellar disequilibrium.
01:20
There's prominent gait ataxia and
imbalance, dysarthric of speech.
01:24
And on examination, we find all
of those cerebellar findings.
01:28
So this isn't vertigo.
It's not syncope,
we're dealing with disequilibrium.
01:34
And then importantly, for this case,
are the imaging findings.
01:37
We see edema or problems in
the deep cerebellar nuclei,
not in the hemispheres
of the white matter,
but in those
deep cerebellar nuclei.
01:46
So we're looking for a problem
that has a predilection
for the nuclei of the cerebellum.
01:52
So what is the most
likely diagnosis?
Is this metronidazole-induced
to cerebellar toxicity?
Is this a
post-infectious cerebellitis?
Is this a cerebellar stroke?
Or could this be
hepatic encephalopathy?
We don't like
hepatic encephalopathy.
02:08
In liver disease,
which the patient has
can cause hyperammonemia
and hepatic encephalopathy.
02:14
But that's an
encephalopathy syndrome.
02:17
Patients are confused and altered
with varying degrees of sedation.
02:21
This patient has no encephalopathy,
and isolated cerebellar signs.
02:26
So this is inconsistent
with hepatic encephalopathy.
02:30
This doesn't sound like
a cerebellar stroke.
02:32
Strokes again,
are acute in onset,
and this was more
subacute in its onset.
02:37
In addition,
the MRI changes are very specific
to the deep cerebellar
gray matter nuclei.
02:42
Their bilateral and symmetric.
02:44
And typically we think of a stroke
as being asymmetric
on one side of the other,
and often affecting
the circumferential vessels
as they course around
the cerebellum
and affecting the hemispheres
and hemispheric function.
02:58
Post infectious cerebellitis
can be seen after an infection,
but that's typically not something
we see after an osteomyelitis.
03:05
Typically, we see this after
some type of viral infection.
03:08
And importantly,
post-infectious cerebellitis
affects the hemispheres.
03:13
Sometimes one
or the other hemispheres,
and sometimes bilaterally,
but the hemispheres of the
predominant area that are affected.
03:20
And here we have a specific process
that has a tropism or predilection
for the deep gray matter
of the cerebellum.
03:28
And this is a typical case of
metronidazole-induced
cerebellar neurotoxicity.
03:34
This is an uncommon condition,
but we see it frequently.
03:37
Metronidazole has a predilection
for the dentate nucleus,
and the deep
gray matter structures.
03:42
And so as neurologist,
and when evaluating
neurologic patients
with neurologic disease,
this is a condition
we want to understand.
03:50
Let's talk for a minute about
Metronidazole-Associated
Cerebellar Neurotoxicity.
03:55
It's one of those conditions
that reminds us
of the importance
for understanding,
what those
deep cerebellar nuclei are?
This is a subacute onset
cerebellar ataxia.
04:05
That presents in patients
who have been taking metronidazole.
04:08
Often at moderate to high doses
for a extended period of time.
04:12
Patients present in a subacute
fashion over several days to weeks,
with primary ataxia.
04:18
Both affecting the trunk,
as well as appendicular function.
04:22
And symptoms occurred during a
prolonged course of metronidazole.
04:27
Imaging is very specific
and shows us
the T2-weighted or
FLAIR hyperintensity,
as we saw in this case,
that affects the
bilateral dentate nuclei.
04:35
Those are susceptible to this
metronidazole induced toxicity.
04:40
What's going on pathologically?
Well we see edema or swelling
within the dentate nuclei
that caused this
characteristic imaging finding.
04:47
Typically this resolves with removal
of the offending agent
stopping the metronidazole,
and in patients improve gradually,
over the next several weeks
and sometimes months.
04:57
Many returning back
to normal function.